MicroTech Medical (Hangzhou) Co (HKSE:02235) Cash Flow for Dividends: HK$-0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02235 MicroTech Medical (Hangzhou) Co Ltd HKSE:02235
80 GF Score
Price HK$7.26
GF Value HK$15.94
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is MicroTech Medical (Hangzhou) Co Cash Flow for Dividends?

MicroTech Medical (Hangzhou) Co HKSE:02235 +1.47% 80 Cash Flow for Dividends is HK$-0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02235 with a GF Score™ of 80/100 and a GF Value™ of HK$15.94 (Possible Value Trap). The stock has 6 warning signs investors should review.

MicroTech Medical (Hangzhou) Co's cash flow for dividends for the six months ended in Dec. 2025 was HK$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

MicroTech Medical (Hangzhou) Co's quarterly payment of dividends increased from Dec. 2024 (HK$0.0 Mil) to Jun. 2025 (HK$-0.1 Mil) but then declined from Jun. 2025 (HK$-0.1 Mil) to Dec. 2025 (HK$0.0 Mil).

MicroTech Medical (Hangzhou) Co's annual payment of dividends increased from Dec. 2023 (HK$0.0 Mil) to Dec. 2024 (HK$-0.7 Mil) but then declined from Dec. 2024 (HK$-0.7 Mil) to Dec. 2025 (HK$-0.0 Mil).

MicroTech Medical (Hangzhou) Co Cash Flow for Dividends Related Terms

MicroTech Medical (Hangzhou) Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for MicroTech Medical (Hangzhou) Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroTech Medical (Hangzhou) Co Cash Flow for Dividends Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.71 -0.02

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.07 0.04
HKSE:02235
80GF Score
MicroTech Medical (Hangzhou) Co Ltd HKSE:02235
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MicroTech Medical (Hangzhou) Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$-0.0 Mil mean?
MicroTech Medical (Hangzhou) Co (HKSE:02235) has a Cash Flow for Dividends of HK$-0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for MicroTech Medical (Hangzhou) Co and its competitors.
Is MicroTech Medical (Hangzhou) Co's Cash Flow for Dividends too high?
MicroTech Medical (Hangzhou) Co's current Cash Flow for Dividends is HK$-0.0 Mil. Overall, MicroTech Medical (Hangzhou) Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroTech Medical (Hangzhou) Co's Cash Flow for Dividends compare to ABT and SYK?
MicroTech Medical (Hangzhou) Co's Cash Flow for Dividends of HK$-0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for MicroTech Medical (Hangzhou) Co and its competitors. MicroTech Medical (Hangzhou) Co's current Cash Flow for Dividends is HK$-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroTech Medical (Hangzhou) Co stock overvalued right now?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co (HKSE:02235) is currently considered Possible Value Trap. The stock's GF Value™ is HK$15.94, compared to a current price of HK$7.26 — trading 54.5% below its estimated fair value. The current Cash Flow for Dividends is HK$-0.0 Mil. MicroTech Medical (Hangzhou) Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For MicroTech Medical (Hangzhou) Co (HKSE:02235), the current Cash Flow for Dividends is HK$-0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroTech Medical (Hangzhou) Co (HKSE:02235) Overvalued in 2026?

Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co stock appears to be undervalued. The current stock price of HK$7.26 is trading 54.5% below its estimated GF Value™ of HK$15.94. GuruFocus considers MicroTech Medical (Hangzhou) Co to be Possible Value Trap.

Key valuation signals for HKSE:02235:

  • Cash Flow for Dividends: HK$-0.0 Mil
  • GF Value™: HK$15.94 vs. price of HK$7.26 (54.5% below fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the HKSE:02235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroTech Medical (Hangzhou) Co Business Description

Address No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
80GF Score

Get the complete analysis for HKSE:02235

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.26
Price
HK$15.94
GF Value